Skip to content

Efficacy of Home-Based Posture Exercises as an Addition to Pharmacological Treatment in Fibromyalgia

Efficacy of Home-Based Posture Exercises as an Addition to Pharmacological Treatment in Fibromyalgia

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06738472
Enrollment
55
Registered
2024-12-17
Start date
2025-01-25
Completion date
2025-12-28
Last updated
2026-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibromyalgia

Keywords

fibromyalgia, home-based therapy, pain, quality of life

Brief summary

This interventional study aimed to evaluate the effects of home exercise in addition to pharmacological treatment on pain threshold and spinal mobility in fibromyalgia patients.

Detailed description

Fibromyalgia (FM) is a chronic pain syndrome characterized by widespread musculoskeletal pain, altered pain processing, fatigue, and functional limitations. In addition to pain-related symptoms, individuals with FM frequently present with postural alterations, reduced spinal mobility, and impaired segmental control of the spine, which may contribute to functional disability and reduced quality of life. However, objective assessment of spinal posture and segmental mobility in FM remains limited. This study aims to comprehensively evaluate spinal posture and sagittal plane mobility in patients with fibromyalgia using the Spinal Mouse®, a validated, non-invasive, computer-assisted device that measures spinal curvature and segmental inclination without radiation exposure. The Spinal Mouse allows for reliable assessment of thoracic and lumbar spinal alignment as well as dynamic movement patterns during functional tasks.

Interventions

given exercises to the participants

Sponsors

Kirsehir Ahi Evran Universitesi
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Participants were between the ages of 18 and 65, * No diagnosis of rheumatic disease, * No diagnosis of chronic comorbid disease, * Participants diagnosed with fibromyalgia syndrome according to the European League Against Rheumatism (EULAR) criteria will be included as volunteers.

Exclusion criteria

* Patients under 18, over 65 years of age * Those diagnosed with chronic comorbid diseases * Those with a history of rheumatic disease

Design outcomes

Primary

MeasureTime frameDescription
Algometry4 weekspain pressure threshold
Spinal mouse for spinal mobility4 weeksspinal range of motion

Secondary

MeasureTime frameDescription
Hospital Anxiety and Depression Scale (HADS)4 weeksused to assess anxiety and depressive symptoms in clinical populations
Pittsburgh Sleep Quality Index (PSQI)4 weeksQuality of Sleep
Short form-12 (SF-12)4 weeksQuality of Life

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026